EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

168 hedge funds and large institutions have $617M invested in Eagle Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 61 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
-8
Holders Change %
-4.55%
% of All Funds
3.71%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
18
Increased
59
Reduced
61
Closed
23
Calls
$795K
Puts
$3.59M
Net Calls
-$2.8M
Net Calls Change
-$13.2M

Top Buyers

1
TCM
Tang Capital Management
California
+$11.8M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$9.35M
3
Goldman Sachs
Goldman Sachs
New York
+$8.7M
4
CS
Credit Suisse
Switzerland
+$7.49M
5
BIP
Brandes Investment Partners
California
+$6.69M

Top Sellers

1
HEC
Hudson Executive Capital
New York
-$39.8M
2
BlackRock
BlackRock
New York
-$6.29M
3
Invesco
Invesco
Georgia
-$4.28M
4
MCM
Matarin Capital Management
New York
-$3.76M
5
PAM
Panagora Asset Management
Massachusetts
-$3.08M
Name Holding Trade Value Shares
Change 		Shares
Change %
MCM
26
Matarin Capital Management
New York
$4.06M -$3.76M -81,735 -48%
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$4.05M +$2.96M +64,413 +273%
Principal Financial Group
28
Principal Financial Group
Iowa
$3.99M -$144K -3,131 -3%
Ameriprise
29
Ameriprise
Minnesota
$3.95M -$9.89K -215 -0.2%
SI
30
Scout Investments
Missouri
$3.9M -$235K -5,109 -6%
FP
31
Foundry Partners
Minnesota
$3.89M +$654K +14,220 +20%
PAMU
32
Pictet Asset Management (UK)
United Kingdom
$3.89M +$1.36M +29,600 +54%
Aviva
33
Aviva
United Kingdom
$3.88M +$3.88M +84,443 New
JIM
34
Jupiter Investment Management
United Kingdom
$3.85M -$295K -6,407 -7%
Bank of America
35
Bank of America
North Carolina
$3.85M -$28.2K -614 -0.7%
Capital Fund Management (CFM)
36
Capital Fund Management (CFM)
France
$3.52M +$1.29M +28,016 +58%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$3.47M +$186K +4,052 +6%
Man Group
38
Man Group
United Kingdom
$3.16M -$762K -16,566 -19%
JPMorgan Chase & Co
39
JPMorgan Chase & Co
New York
$3.15M -$362K -7,875 -10%
Russell Investments Group
40
Russell Investments Group
United Kingdom
$3.01M +$405K +8,803 +16%
Jacobs Levy Equity Management
41
Jacobs Levy Equity Management
New Jersey
$2.91M +$1.95M +42,381 +203%
Charles Schwab
42
Charles Schwab
California
$2.77M -$2.28M -49,640 -45%
MAM
43
Martingale Asset Management
Massachusetts
$2.56M +$916K +19,900 +56%
William Blair & Company
44
William Blair & Company
Illinois
$2.45M -$241K -5,240 -9%
RA
45
Royce & Associates
New York
$2.38M +$76.4K +1,661 +3%
CTA
46
Carillon Tower Advisers
Florida
$2.37M -$253K -5,500 -10%
Morgan Stanley
47
Morgan Stanley
New York
$2.27M -$988K -21,473 -30%
Fidelity Investments
48
Fidelity Investments
Massachusetts
$2.23M +$8.37K +182 +0.4%
CAM
49
ClariVest Asset Management
California
$2.1M +$41.6K +905 +2%
Nuveen Asset Management
50
Nuveen Asset Management
Illinois
$2.04M +$51.1K +1,111 +3%
1
2
3 4 5